Yuval Shaked, Ph.D., is the Head of the Technion Integrated Cancer Center and a professor at the Rappaport Faculty of Medicine. They co-founded OncoHost and REMEDY CELL Ltd., serving as Chief Scientific Advisor for both organizations. Yuval's research focuses on the host response to cancer therapy, identifying over 30 new targets for cancer treatment, which are currently undergoing preclinical testing. Their educational background includes a Ph.D. in Pre-Medicine from the Hebrew University of Jerusalem and postdoctoral training at Sunnybrook Health Sciences Centre, where they studied circulating endothelial cells related to cancer treatment.
This person is not in the org chart
This person is not in any teams
This person is not in any offices